Overview of Glp 1 And Anesthesia Considerations And Cautions For Crnas
With drugs like Ozempic and Wegovy growing in popularity among diabetic patients, CRNAs must be aware of all potential GLP-1 and anesthesia conflicts.
To support the safety of patients and the knowledge of anesthesia professionals, such as Certified Registered Nurse Anesthetists ( CRNAs ), also known as nurse anesthesiologists or nurse anesthetists, the American Association of Nurse Anesthesiology (AANA) has published " Anesthesia Care of the Patient on a GLP-1 Receptor Agonist."
Key Details About Glp 1 And Anesthesia Considerations And Cautions For Crnas
GLP-1 drugs like Ozempic and Wegovy are common in surgical patients. Learn 2025 anesthesia guidelines CRNAs need for safe perioperative care.
Certified Registered Nurse Anesthetists ( CRNAs ) may care for patients taking Glucagon-like peptide-1 ( GLP-1 ) agonists, designed initially to manage type 2 diabetes. Due to the increased popularity and use of GLP-1 agonists in promoting weight loss, anesthesia professionals need to be prepared for patients who are actively taking these drugs.1-3 1-3
American Society of Anesthesiologists Consensus
During the conduct of general anesthesia /deep sedation, children on GLP-1 agonists have similar gastrointestinal adverse events at a rate similar to adults. The American Society of Anesthesiologists (ASA) Task Force on Preoperative Fasting reviewed the available literature on GLP-1 agonists and associated gastrointestinal adverse effects ...
The GLP-1 agonists are associated with adverse gastrointestinal effects such as nausea, vomiting and delayed gastric emptying. Based on recent anecdotal reports, there are concerns that delayed gastric emptying from GLP-1 agonists can increase the risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation. The presence of adverse ...
Perioperative management of patients on GLP
This flowchart outlines the steps for managing patients on GLP-1 receptor agonists during the perioperative period, including risk assessment, preoperative preparation, anesthesia induction, and postoperative monitoring.
Most patients should continue taking their glucagon-like peptide-1 ( GLP-1 ) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of ...
Elective perioperative management of adults taking glucagonlike ...
The most common indication for GLP-1 RAs other than diabetes mellitus is obesity, and further indications are under investigation, including: osteoarthritis; obstructive sleep apnoea; metabolic dysfunction-associated steatotic liver disease; and metabolic dysfunction-associated steatohepatitis [4].
Editor's key points With their wide adoption into clinical practice for the treatment of obesity diabetes mellitus and other conditions, more patients taking glucagon-like pep-tide 1 receptor agonists ( GLP-1 RAs) are presenting for procedures requiring anaesthesia.